12/27
09:15 am
vcyt
Here's Why VCYT Stock Could be a Great Addition to Your Portfolio Now [Yahoo! Finance]
Low
Report
Here's Why VCYT Stock Could be a Great Addition to Your Portfolio Now [Yahoo! Finance]
12/19
02:12 pm
vcyt
Is Your Portfolio Missing These 5 High-Growth Healthcare Stocks? [Yahoo! Finance]
Low
Report
Is Your Portfolio Missing These 5 High-Growth Healthcare Stocks? [Yahoo! Finance]
12/16
01:22 pm
vcyt
3 Medical Instruments Industry Stocks to Buy on the GenAI Wave [Yahoo! Finance]
Low
Report
3 Medical Instruments Industry Stocks to Buy on the GenAI Wave [Yahoo! Finance]
12/11
01:28 pm
vcyt
Those who invested in Veracyte (NASDAQ:VCYT) a year ago are up 68% [Yahoo! Finance]
Neutral
Report
Those who invested in Veracyte (NASDAQ:VCYT) a year ago are up 68% [Yahoo! Finance]
12/5
04:13 pm
vcyt
Veracyte's Decipher Prostate Test Is Now the Only Gene Expression Test Recommended in NCCN® Prostate Cancer Guidelines [Yahoo! Finance]
Low
Report
Veracyte's Decipher Prostate Test Is Now the Only Gene Expression Test Recommended in NCCN® Prostate Cancer Guidelines [Yahoo! Finance]
12/5
04:05 pm
vcyt
Veracyte’s Decipher Prostate Test Is Now the Only Gene Expression Test Recommended in NCCN® Prostate Cancer Guidelines
Medium
Report
Veracyte’s Decipher Prostate Test Is Now the Only Gene Expression Test Recommended in NCCN® Prostate Cancer Guidelines
12/5
08:01 am
vcyt
Veracyte, Inc. (NASDAQ: VCYT) had its "neutral" rating re-affirmed by analysts at The Goldman Sachs Group, Inc.. They now have a $37.00 price target on the stock, down previously from $38.00.
Low
Report
Veracyte, Inc. (NASDAQ: VCYT) had its "neutral" rating re-affirmed by analysts at The Goldman Sachs Group, Inc.. They now have a $37.00 price target on the stock, down previously from $38.00.
11/18
10:31 am
vcyt
Veracyte, Inc. (NASDAQ: VCYT) had its price target raised by analysts at Morgan Stanley from $26.00 to $28.00. They now have an "underweight" rating on the stock.
Low
Report
Veracyte, Inc. (NASDAQ: VCYT) had its price target raised by analysts at Morgan Stanley from $26.00 to $28.00. They now have an "underweight" rating on the stock.
11/15
08:28 am
vcyt
Veracyte, Inc. (NASDAQ: VCYT) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $50.00 price target on the stock.
Medium
Report
Veracyte, Inc. (NASDAQ: VCYT) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $50.00 price target on the stock.
11/9
08:53 am
vcyt
Veracyte, Inc. Just Recorded A 296% EPS Beat: Here's What Analysts Are Forecasting Next [Yahoo! Finance]
Medium
Report
Veracyte, Inc. Just Recorded A 296% EPS Beat: Here's What Analysts Are Forecasting Next [Yahoo! Finance]
11/8
10:34 am
vcyt
Veracyte, Inc. (NASDAQ: VCYT) had its price target raised by analysts at Scotiabank from $40.00 to $44.00. They now have a "sector outperform" rating on the stock.
Low
Report
Veracyte, Inc. (NASDAQ: VCYT) had its price target raised by analysts at Scotiabank from $40.00 to $44.00. They now have a "sector outperform" rating on the stock.
11/8
06:36 am
vcyt
Veracyte Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
Medium
Report
Veracyte Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
11/7
12:35 pm
vcyt
Veracyte Q3 Earnings Beat Estimates, 2024 Guidance Raised [Yahoo! Finance]
Medium
Report
Veracyte Q3 Earnings Beat Estimates, 2024 Guidance Raised [Yahoo! Finance]
11/7
12:32 pm
vcyt
Veracyte, Inc. (NASDAQ: VCYT) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $34.00 to $38.00. They now have a "buy" rating on the stock.
Medium
Report
Veracyte, Inc. (NASDAQ: VCYT) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $34.00 to $38.00. They now have a "buy" rating on the stock.
11/7
11:20 am
vcyt
Veracyte, Inc. (NASDAQ: VCYT) had its price target raised by analysts at UBS Group AG from $43.00 to $46.00. They now have a "buy" rating on the stock.
Medium
Report
Veracyte, Inc. (NASDAQ: VCYT) had its price target raised by analysts at UBS Group AG from $43.00 to $46.00. They now have a "buy" rating on the stock.
11/7
10:28 am
vcyt
Veracyte Inc (VCYT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Outlook [Yahoo! Finance]
Medium
Report
Veracyte Inc (VCYT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Outlook [Yahoo! Finance]
11/7
08:36 am
vcyt
Veracyte, Inc. (NASDAQ: VCYT) had its price target raised by analysts at Needham & Company LLC from $37.00 to $44.00. They now have a "buy" rating on the stock.
Low
Report
Veracyte, Inc. (NASDAQ: VCYT) had its price target raised by analysts at Needham & Company LLC from $37.00 to $44.00. They now have a "buy" rating on the stock.
11/6
07:28 pm
vcyt
Veracyte (VCYT) Tops Q3 Earnings and Revenue Estimates [Yahoo! Finance]
Medium
Report
Veracyte (VCYT) Tops Q3 Earnings and Revenue Estimates [Yahoo! Finance]
11/6
04:54 pm
vcyt
Veracyte Announces Third Quarter 2024 Financial Results [Yahoo! Finance]
Medium
Report
Veracyte Announces Third Quarter 2024 Financial Results [Yahoo! Finance]
11/6
04:05 pm
vcyt
Veracyte Announces Third Quarter 2024 Financial Results
Low
Report
Veracyte Announces Third Quarter 2024 Financial Results
11/5
07:56 am
vcyt
What To Expect From Veracyte Inc (VCYT) Q3 2024 Earnings [Yahoo! Finance]
Low
Report
What To Expect From Veracyte Inc (VCYT) Q3 2024 Earnings [Yahoo! Finance]
10/30
05:00 pm
vcyt
Veracyte to Participate in Upcoming Investor Conferences
Medium
Report
Veracyte to Participate in Upcoming Investor Conferences
10/17
03:15 pm
vcyt
Ark Invest's flagship fund realized $3.5 billion in losses in a year. Here were its 10 biggest losers. [Yahoo! Finance]
Low
Report
Ark Invest's flagship fund realized $3.5 billion in losses in a year. Here were its 10 biggest losers. [Yahoo! Finance]
10/17
11:36 am
vcyt
Veracyte, Inc. (NASDAQ: VCYT) had its price target raised by analysts at Leerink Partners from $35.00 to $40.00. They now have an "outperform" rating on the stock.
Low
Report
Veracyte, Inc. (NASDAQ: VCYT) had its price target raised by analysts at Leerink Partners from $35.00 to $40.00. They now have an "outperform" rating on the stock.
10/16
06:50 pm
vcyt
Veracyte to Release Third Quarter 2024 Financial Results on November 6, 2024 [Yahoo! Finance]
Medium
Report
Veracyte to Release Third Quarter 2024 Financial Results on November 6, 2024 [Yahoo! Finance]